S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
LON:SIS

Science in Sport (SIS) Share Price, News & Analysis

GBX 15.75
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
15.50
15.75
50-Day Range
15.10
17.75
52-Week Range
9
18
Volume
74,506 shs
Average Volume
332,514 shs
Market Capitalization
£28.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SIS stock logo

About Science in Sport Stock (LON:SIS)

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally. It operates through Science in Sport and PhD Nutrition segments. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; vitamins and supplements; diet whey; high protein and low sugar foods, bars, and snacks; high protein and low sugar plant-based complete meal solution; and Reset, a night time formula. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains, and specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, and third-party online sites. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.

SIS Stock Price History

SIS Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
See More Headlines
Receive SIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Science in Sport and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/16/2020
Today
4/20/2024

Industry, Sector and Symbol

Industry
Packaged Foods
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
320
Year Founded
N/A

Profitability

Net Income
£-7,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£65.93 million
Cash Flow
GBX (2.17) per share
Book Value
GBX 22 per share

Miscellaneous

Free Float
N/A
Market Cap
£28.39 million
Optionable
Not Optionable
Beta
0.51
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Daniel Malachy Lampard (Age 44)
    CFO, Secretary & Executive Director
    Comp: $240k
  • Mr. Stephen Nigel Moon MBA (Age 67)
    Executive Director (Garden Leave)
    Comp: $398k
  • Mr. Daniel Patrick Wright (Age 52)
    Executive Chairman
  • Ms. Bernadette Ude-Wetherell
    Chief People Officer
  • Mr. Andy Bott
    Chief Commercial Officer

SIS Stock Analysis - Frequently Asked Questions

How have SIS shares performed in 2024?

Science in Sport's stock was trading at GBX 11.75 at the start of the year. Since then, SIS shares have increased by 34.0% and is now trading at GBX 15.75.
View the best growth stocks for 2024 here
.

How were Science in Sport's earnings last quarter?

Science in Sport plc (LON:SIS) issued its quarterly earnings data on Wednesday, September, 16th. The company reported ($1.80) earnings per share (EPS) for the quarter. Science in Sport had a negative net margin of 10.72% and a negative trailing twelve-month return on equity of 18.91%.

What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival Co. & (CCL), Bellway (BWY), British American Tobacco (BTI), boohoo group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

How do I buy shares of Science in Sport?

Shares of SIS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SIS) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners